Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Dexamethasone × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 52 Recurrence 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Burkitt Lymphoma 6 Lymphoma, Large B-Cell, Diffuse 5 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms, Plasma Cell 4 Lymphoma 4 Nausea 3 Smoldering Multiple Myeloma 2 Prostatic Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Biphenotypic, Acute 2 Immunoglobulin Light-chain Amyloidosis 2 Down Syndrome 2 Carcinoma, Non-Small-Cell Lung 2 beta-Thalassemia 1 Waldenstrom Macroglobulinemia 1 Thalassemia 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer Metastatic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Paraproteinemias 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lung Neoplasms 1

Interventions

Azacitidine 3 venetoclax 2 Vorinostat 2 Specimen Handling 2 Biopsy 2 thymoglobulin 1 fludarabine phosphate 1 fludarabine 1 decitabine and cedazuridine drug combination 1 cedazuridine 1 TAK-243 1 Rituximab 1 Melphalan 1 Levetiracetam 1 Lenalidomide 1 Injections 1 Idarubicin 1 Granulocyte Colony-Stimulating Factor 1 Gemtuzumab 1 Filgrastim 1 Decitabine 1 Cytarabine 1 Cyclophosphamide 1 Clinical Trials, Phase I as Topic 1 Busulfan 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡